CARISMA THERAP (CARM)
(Delayed Data from NSDQ)
$1.13 USD
-0.06 (-5.04%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.15 +0.02 (1.77%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 25.00% |
ABR | 1.00 |
Earnings ESP
|
-16.22% |
---|---|
Current Year | -1.43 |
Next Year | -1.43 |
EPS (TTM) | -1.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.65M | 3.60M | 17.15M | 15.20M |
# of Estimates | 2 | 2 | 2 | 1 |
High Estimate | 3.80M | 3.70M | 19.59M | 15.20M |
Low Estimate | 3.50M | 3.50M | 14.70M | 15.20M |
Year ago Sales | 3.83M | 4.29M | 14.92M | 17.15M |
Year over Year Growth Est. | -4.70% | -16.08% | 14.92% | -11.34% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.33 | -1.43 | -1.43 |
# of Estimates | 2 | 2 | 2 | 3 |
Most Recent Consensus | -0.43 | -0.37 | -1.53 | -1.78 |
High Estimate | -0.31 | -0.28 | -1.33 | -0.99 |
Low Estimate | -0.43 | -0.37 | -1.53 | -1.78 |
Year ago EPS | -0.53 | -0.52 | -2.59 | -1.43 |
Year over Year Growth Est. | 30.19% | 36.54% | 44.79% | -0.23% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.33 | -1.43 | -1.43 |
7 Days Ago | -0.37 | -0.33 | -1.43 | -1.43 |
30 Days Ago | -0.37 | -0.38 | -1.56 | -1.53 |
60 Days Ago | -0.37 | -0.38 | -1.56 | -1.53 |
90 Days Ago | -0.37 | -0.38 | -1.56 | -1.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.37 | -1.53 | -1.78 |
Zacks Consensus Estimate | -0.37 | -0.33 | -1.43 | -1.43 |
Earnings ESP | -16.22% | -13.85% | -6.99% | -24.19% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.46 | -0.52 | -0.53 | NA |
Estimate | -0.36 | -0.37 | -0.56 | -0.60 | NA |
Difference | 0.09 | -0.09 | 0.04 | 0.07 | 0.03 |
Surprise | 25.00% | -24.32% | 7.14% | 11.67% | 4.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more